- Home
- AXSM vs CTRE Comparison
AXSM vs CTRE Comparison
Compare AXSM & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- CTRE
- Stock Information
- Founded
- AXSM 2012
- CTRE 2013
- Country
- AXSM United States
- CTRE United States
- Employees
- AXSM N/A
- CTRE N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- CTRE Real Estate Investment Trusts
- Sector
- AXSM Health Care
- CTRE Real Estate
- Exchange
- AXSM Nasdaq
- CTRE Nasdaq
- Market Cap
- AXSM 5.1B
- CTRE 5.7B
- IPO Year
- AXSM 2015
- CTRE N/A
- Fundamental
- Price
- AXSM $108.98
- CTRE $30.73
- Analyst Decision
- AXSM Strong Buy
- CTRE Buy
- Analyst Count
- AXSM 17
- CTRE 7
- Target Price
- AXSM $171.65
- CTRE $31.00
- AVG Volume (30 Days)
- AXSM 636.2K
- CTRE 2.2M
- Earning Date
- AXSM 08-04-2025
- CTRE 07-31-2025
- Dividend Yield
- AXSM N/A
- CTRE 4.36%
- EPS Growth
- AXSM N/A
- CTRE 73.08
- EPS
- AXSM N/A
- CTRE 0.95
- Revenue
- AXSM $432,157,000.00
- CTRE $329,837,000.00
- Revenue This Year
- AXSM $62.84
- CTRE $16.16
- Revenue Next Year
- AXSM $60.02
- CTRE $16.18
- P/E Ratio
- AXSM N/A
- CTRE $32.31
- Revenue Growth
- AXSM 72.16
- CTRE 43.26
- 52 Week Low
- AXSM $72.21
- CTRE $24.79
- 52 Week High
- AXSM $139.13
- CTRE $33.15
- Technical
- Relative Strength Index (RSI)
- AXSM 56.00
- CTRE 60.27
- Support Level
- AXSM $102.26
- CTRE $29.91
- Resistance Level
- AXSM $114.66
- CTRE $31.50
- Average True Range (ATR)
- AXSM 3.49
- CTRE 0.51
- MACD
- AXSM 0.92
- CTRE -0.01
- Stochastic Oscillator
- AXSM 61.89
- CTRE 54.23
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.